Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MJR-35 (dienogest) Phase 3 Study in Dysmenorrhea
jRCT2080223492Phase 3Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dysmenorrhea, primary dysmenorrhea (PD) and Secondary dysmenorrhea comparing MJR-35 (dienogest) with Placebo (2 arms). Started Mar 2017; status: completed.
02
Drugs
dienogest
03
Conditions
dysmenorrheaprimary dysmenorrhea (PD)Secondary dysmenorrhea
Beyond the preview
Go deeper on jRCT2080223492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223492.